1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Pancreatic Adenocarcinoma : Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
- Contribution to journal › Article
- 2022
-
Mark
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed : The Study Protocol for the Randomized Controlled NEEDS Trial
Nilsson, Magnus LU ; Olafsdottir, Halla ; Alexandersson von Döbeln, Gabriella ; Villegas, Fernanda ; Gagliardi, Giovanna ; Hellström, Mats ; Wang, Qiao Li LU
; Johansson, Hemming
; Gebski, Val
and Hedberg, Jakob
, et al.
(2022)
In Frontiers in Oncology
12.
- Contribution to journal › Article
- 2017
-
Mark
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4) : A multicentre, open-label, randomised, phase 3 trial
- Contribution to journal › Article